Y. Cohen

发表

BRAF mutation in papillary thyroid carcinoma.

P. Ladenson, Zhongmin Guo, B. Trink, 2003, Journal of the National Cancer Institute.

C1824T mutation in the LMNA gene has no association with senile cataract

A. Simon, Y. Cohen, N. Goldenberg-Cohen, 2012, Neurobiology of Aging.

Colorimetric approach to high-throughput mutation analysis.

J. Califano, D. Sidransky, N. Benoit, 2005, BioTechniques.

Anatomy and Pathology The Role of RASSF 1 A in Uveal Melanoma

J. Pe’er, Y. Cohen, Efrat Merhavi-Shoham, 2012 .

The role of RASSF1A in uveal melanoma.

J. Pe’er, Y. Cohen, Efrat Merhavi-Shoham, 2012, Investigative ophthalmology & visual science.

Promoter methylation status of multiple genes in uveal melanoma.

I. Chowers, J. Pe’er, Y. Cohen, 2007, Investigative Ophthalmology and Visual Science.

BRAF and GNAQ mutations in melanocytic tumors of the oral cavity.

I. Barshack, S. Akrish, N. Amariglio, 2012, Oral surgery, oral medicine, oral pathology and oral radiology.

Exon 15 BRAF Mutations Are Uncommon in Melanomas Arising in Nonsun-Exposed Sites

D. Sidransky, W. Westra, D. Goldenberg, 2004, Clinical Cancer Research.

BRCA1/2 mutations and FMR1 alleles are randomly distributed: a case control study

R. Gershoni-baruch, E. Dagan, A. Kurolap, 2014, European Journal of Human Genetics.

BRCA1/2 mutations and FMR1 alleles are randomly distributed: a case control study

R. Gershoni-baruch, E. Dagan, A. Kurolap, 2013, European Journal of Human Genetics.

Sequence variants in HTRA1 and LOC387715/ARMS2 and phenotype and response to photodynamic therapy in neovascular age-related macular degeneration in populations from Israel

I. Chowers, D. Zack, J. Hoh, 2008, Molecular vision.

Lack of oncogenic GNAQ mutations in melanocytic lesions of the conjunctiva as compared to uveal melanoma.

J. Pe’er, Y. Cohen, S. Frenkel, 2010, Investigative ophthalmology & visual science.

T1799A BRAF mutations in conjunctival melanocytic lesions.

I. Chowers, D. Weinberger, D. Sidransky, 2005, Investigative ophthalmology & visual science.

Mutational Analysis of BRAF in Fine Needle Aspiration Biopsies of the Thyroid: A Potential Application for the Preoperative Assessment of Thyroid Nodules

D. Clark, D. Sidransky, W. Westra, 2004, Clinical Cancer Research.

BRAF mutations in anaplastic thyroid carcinoma: implications for tumor origin, diagnosis and treatment

D. Sidransky, W. Westra, R. Henrique, 2004, Modern Pathology.

Lack of BRAF mutation in primary uveal melanoma.

I. Chowers, D. Sidransky, J. Pe’er, 2003, Investigative ophthalmology & visual science.

Mutational analysis of PTEN/PIK3CA/AKT pathway in oral squamous cell carcinoma.

B. Shalmon, N. Amariglio, Y. Cohen, 2011, Oral oncology.

JAK2V617F allele burden is associated with transformation to myelofibrosis

A. Nagler, N. Amariglio, Y. Cohen, 2012, Leukemia & lymphoma.

A new MALDI-TOF-based assay for monitoring JAK2 V617F mutation level in patients undergoing allogeneic stem cell transplantation (allo SCT) for classic myeloproliferative disorders (MPD).

A. Nagler, L. Trakhtenbrot, N. Amariglio, 2008, Leukemia research.

The disappearance of two alleles of JAK2 V617F from peripheral blood of a polycythaemia vera patient correlates with transformation into myelofibrosis

A. Nagler, O. Ashur-Fabian, N. Amariglio, 2007, British journal of haematology.

Detection of LOH and Mitochondrial DNA Alterations in Ductal Lavage and Nipple Aspirate Fluids from High-risk Patients

Minetta C. Liu, Baljit Singh, C. Isaacs, 2004, Breast Cancer Research and Treatment.

Possible neuroprotective effect of brimonidine in a mouse model of ischaemic optic neuropathy

D. Weinberger, Y. Cohen, M. Hasanreisoğlu, 2009, Clinical & experimental ophthalmology.

AKT1 pleckstrin homology domain E17K activating mutation in endometrial carcinoma.

B. Shalmon, E. Fridman, I. Barshack, 2010, Gynecologic oncology.

PI3K/Akt pathway mutations in retinoblastoma.

J. Pe’er, Y. Cohen, Michael J Savetsky, 2009, Investigative ophthalmology & visual science.

AKT1 E17 K pleckstrin homology domain mutation in urothelial carcinoma.

E. Fridman, N. Amariglio, G. Rechavi, 2009, Cancer genetics and cytogenetics.

BRCA germline mutations in Jewish women with uterine serous papillary carcinoma.

G. Rennert, Y. Cohen, U. Beller, 2004, Gynecologic oncology.

Is uterine serous papillary carcinoma a BRCA1-related disease? Case report and review of the literature.

E. Levy-Lahad, Y. Cohen, U. Beller, 1999, Gynecologic oncology.

High-throughput, sensitive and quantitative assay for the detection of BCR-ABL kinase domain mutations

A. Nagler, O. Ashur-Fabian, N. Amariglio, 2007, Leukemia.

Epstein‐Barr Virus in Head and Neck Cancer Assessed by Quantitative Polymerase Chain Reaction

J. Califano, D. Sidransky, W. Westra, 2004, The Laryngoscope.

The GALT rush: high carrier frequency of an unusual deletion mutation of the GALT gene in the Ashkenazi population.

B. Pode-Shakked, Y. Anikster, L. Peleg, 2011, Molecular genetics and metabolism.

Increased Plasma and Optic Nerve Levels of IL-6, TNF-α, and MIP-2 Following Induction of Ischemic Optic Neuropathy in Mice

D. Weinberger, M. Kramer, Y. Cohen, 2008, Current eye research.

Prognostic significance of plasma cell morphology in multiple myeloma

S. Linn, Y. Cohen, I. Hocherman, 1987, Cancer.

Pathophysiology Mechanisms in Fragile-X Primary Ovarian Insufficiency.

Y. Cohen, S. Elizur, O. Dratviman-Storobinsky, 2019, Methods in molecular biology.

FMR6 may play a role in the pathogenesis of fragile X-associated premature ovarian insufficiency

O. Lebovitz, Y. Cohen, S. Elizur, 2016, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

FMRpolyG accumulates in FMR1 premutation granulosa cells

Y. Cohen, S. Elizur, A. Aizer, 2020, Journal of Ovarian Research.

resistance A coding VKORC1 Asp36Tyr polymorphism predisposes to warfarin

H. Halkin, N. Amariglio, G. Rechavi, 2013 .

Schimke Immuno-Osseous Dysplasia: Expression of SMARCAL1 in Blood and Kidney Provides Novel Insight Into Disease Phenotype

Y. Anikster, M. Davidovits, Y. Cohen, 2008, Pediatric Research.

Association between a common CYP17A1 haplotype and anxiety in female anorexia nervosa

Abraham Weizman, N. Amariglio, G. Rechavi, 2013, Archives of Women's Mental Health.

Dysregulation of anti-Mullerian hormone expression levels in mural granulosa cells of FMR1 premutation carriers

Y. Cohen, R. Orvieto, M. Kirshenbaum, 2021, Scientific Reports.

Elevated Levels of FMR1 mRNA in Granulosa Cells Are Associated with Low Ovarian Reserve in FMR1 Premutation Carriers

O. Lebovitz, Y. Cohen, S. Elizur, 2014, PloS one.

Fertility Preservation in Young Females with Hematological Malignancies

Y. Cohen, D. Meirow, M. Shapira, 2014, Acta Haematologica.

Does the presence of AGG interruptions within the CGG repeat tract have a protective effect on the fertility phenotype of female FMR1 premutation carriers?

Y. Cohen, S. Elizur, R. Orvieto, 2020, Journal of Assisted Reproduction and Genetics.

Interleukin-2 and SOCS-1 proteins involvement in the pathophysiology of severe ovarian hyperstimulation syndrome-a preliminary proof of concept

Y. Cohen, R. Mashiach, R. Orvieto, 2014, Journal of Ovarian Research.

Inflammatory Reaction in Acute Retinal Artery Occlusion: Cytokine Levels in Aqueous Humor and Serum

D. Weinberger, M. Kramer, Y. Cohen, 2005, Ocular immunology and inflammation.

BRCA2 germline mutation in a woman with uterine serous papillary carcinoma--case report.

G. Rennert, Y. Cohen, O. Lavie, 2005, Gynecologic oncology.

Follicle activation and 'burn-out' contribute to post-transplantation follicle loss in ovarian tissue grafts: the effect of graft thickness.

Y. Cohen, D. Meirow, Z. Gavish, 2014, Human reproduction.

Follicle activation and 'burn-out' contribute to post-transplantation follicle loss in ovarian tissue grafts: the effect of graft thickness.

Y. Cohen, D. Meirow, Z. Gavish, 2015, Human reproduction.

Ovarian follicle burnout: A universal phenomenon?

Y. Cohen, D. Meirow, Z. Gavish, 2013, Cell cycle.

CDC91L1 (PIG-U) is a newly discovered oncogene in human bladder cancer

L. Kiemeney, P. Meltzer, J. Trent, 2004, Nature Medicine.

Association of aberrant methylation of tumor suppressor genes with tumor aggressiveness and BRAF mutation in papillary thyroid cancer

J. Califano, W. Westra, M. Zeiger, 2006, International journal of cancer.

Evaluation of EGFR, KRAS, and TP53 mutations as predictive of disease recurrence in resected early non-small cell lung carcinomas (NSCLCs)

R. Yarden, M. Perelman, I. Barshack, 2014, memo - Magazine of European Medical Oncology.

Donor-Derived Brain Tumor Following Neural Stem Cell Transplantation in an Ataxia Telangiectasia Patient

Gideon Rechavi, Yoram Cohen, Shlomi Constantini, 2009, PLoS medicine.

Promoter methylation patterns of ATM, ATR, BRCA1, BRCA2 and P53 as putative cancer risk modifiers in Jewish BRCA1/BRCA2 mutation carriers

E. Friedman, U. Nir, Y. Cohen, 2009, Breast Cancer Research and Treatment.

Mutations in BRAF and KRAS characterize the development of low-grade ovarian serous carcinoma.

I. Shih, D. Sidransky, G. Singer, 2003, Journal of the National Cancer Institute.

The Human MitoChip: a high-throughput sequencing microarray for mitochondrial mutation detection.

A. Chakravarti, N. Shah, A. Maitra, 2004, Genome research.

Promoter Hypermethylation as an Independent Prognostic Factor for Relapse in Patients with Prostate Cancer Following Radical Prostatectomy

A. Partin, J. Epstein, M. Hoque, 2005, Clinical Cancer Research.

DeltaNp63alpha and TAp63alpha regulate transcription of genes with distinct biological functions in cancer and development.

S. Nomoto, J. Jen, Guojun Wu, 2003, Cancer research.

BRAF mutation predicts a poorer clinical prognosis for papillary thyroid cancer.

P. Ladenson, J. Califano, D. Sidransky, 2005, The Journal of clinical endocrinology and metabolism.

Early Occurrence of RASSF1A Hypermethylation and Its Mutual Exclusion with BRAF Mutation in Thyroid Tumorigenesis

Yoram Cohen, Giovanni Tallini, David Sidransky, 2004, Cancer Research.

The RASSF1A tumor suppressor gene is commonly inactivated in adenocarcinoma of the uterine cervix.

D. Sidransky, G. Singer, S. Dong, 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

The RASSF 1 A Tumor Suppressor Gene Is Commonly Inactivated in Adenocarcinoma of the Uterine Cervix

D. Sidransky, G. Singer, S. Dong, 2003 .

Fragile X Associated Primary Ovarian Insufficiency (FXPOI): Case Report and Literature Review

R. Pyeritz, L. Nelson, Y. Cohen, 2018, Front. Genet..

Preimplantation genetic diagnosis versus prenatal diagnosis—decision-making among pregnant FMR1 premutation carriers

Y. Cohen, S. Elizur, R. Orvieto, 2018, Journal of assisted reproduction and genetics.

Surgically treated ovarian endometriosis association with BRCA1 and BRCA2 mutations.

I. Barshack, S. Aviel-Ronen, D. Soriano, 2014, Pathology, research and practice.

The VKORC1 Asp36Tyr variant and VKORC1 haplotype diversity in Ashkenazi and Ethiopian populations

H. Halkin, D. Kurnik, Y. Cohen, 2014, Journal of Applied Genetics.

FOXL2 C402G mutation detection using MALDI-TOF-MS in DNA extracted from Israeli granulosa cell tumors.

I. Barshack, S. Aviel-Ronen, Y. Cohen, 2011, Gynecologic oncology.

Ethnicity has a multiplex impact upon the risk of a full mutation expansion among female heterozygotes for FMR1 premutation

S. Ben-Shachar, E. Pras, Y. Yaron, 2021, Genetics in Medicine.

Epigenetic inheritance of DNA methylation limits activation-induced expression of FOXP3 in conventional human CD25-CD4+ T cells.

N. Amariglio, G. Rechavi, D. Dominissini, 2008, International immunology.

Detecting cervical cancer by quantitative promoter hypermethylation assay on cervical scrapings: a feasibility study.

Yoram Cohen, David Sidransky, H. Boezen, 2004, Molecular cancer research : MCR.

Apaf1 in Chronic Myelogenous Leukemia (CML) Progression: Reduced Apaf1 Expression is Correlated with a H179R p53 Mutation During Clinical Blast Crisis

A. Nagler, O. Ashur-Fabian, L. Trakhtenbrot, 2007, Cell cycle.

ΔNp63α and TAp63α regulate transcription of genes with distinct biological functions in cancer and development

S. Nomoto, J. Jen, Guojun Wu, 2003 .

Advances in Brief Np 63 and TAp 63 Regulate Transcription of Genes with Distinct Biological Functions in Cancer and Development 1

S. Nomoto, J. Jen, Guojun Wu, 2003 .

Methylation of the thyroid-stimulating hormone receptor gene in epithelial thyroid tumors: a marker of malignancy and a cause of gene silencing.

P. Ladenson, Zhongmin Guo, J. Califano, 2003, Cancer research.

Interleukin‐2 Production by Cultured Human Granulosa Cells

Y. Cohen, R. Orvieto, O. Dratviman-Storobinsky, 1997, American journal of reproductive immunology.

Hypermethylation of CpG island loci of multiple tumor suppressor genes in retinoblastoma.

J. Pe’er, Y. Cohen, Efrat Merhavi-Shoham, 2008, Experimental eye research.

Single-Nucleotide Polymorphisms in IL23R-IL12RB2 (rs1495965) Are Highly Prevalent in Patients with Behcet’s Uveitis and Vary Between Populations

M. Kramer, Sezen Guntekin-Ergun, Y. Cohen, 2019, Ocular immunology and inflammation.

Mutational analysis of PI3K/AKT and RAS/RAF pathway activation in malignant salivary gland tumours with a new mutation of PIK3CA.

B. Shalmon, Y. Cohen, M. Drendel, 2016, International journal of oral and maxillofacial surgery.

In Vitro Exposure of Human Luteinized Mural Granulosa Cells to Dibutyl Phthalate Affects Global Gene Expression

C. Combelles, M. Salmon-Divon, R. Machtinger, 2017, Toxicological sciences : an official journal of the Society of Toxicology.

Genetic mutation screen in early non--small-cell lung cancer (NSCLC) specimens.

M. Perelman, A. Onn, J. Bar, 2014, Clinical lung cancer.

Association of complement factor H Y402H polymorphism with phenotype of neovascular age related macular degeneration in Israel

I. Chowers, I. Hemo, Y. Cohen, 2008, Molecular vision.

A coding VKORC1 Asp36Tyr polymorphism predisposes to warfarin resistance.

H. Halkin, N. Amariglio, G. Rechavi, 2007, Blood.

Breast cancer-associated gene 1/2 mutations are not associated with risk of exudative age-related macular degeneration in Ashkenazi Jews

M. Azab, Y. Cohen, N. Goldenberg-Cohen, 2020 .

High-Throughput Mutation Profiling in Intraductal Papillary Mucinous Neoplasm (IPMN)

G. Rechavi, Y. Cohen, J. Klausner, 2011, Journal of Gastrointestinal Surgery.

Electrophile and oxidant damage of mitochondrial DNA leading to rapid evolution of homoplasmic mutations

Zhongmin Guo, D. Sidransky, E. Mambo, 2003, Proceedings of the National Academy of Sciences of the United States of America.

Do poor-responder patients undergoing IVF benefit from splitting and increasing the daily gonadotropin dose?

R. Nahum, Y. Cohen, E. Maman, 2019, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

Oligodendrocyte dysfunction after induction of experimental anterior optic nerve ischemia.

Yan Guo, Yoram Cohen, Neil R Miller, 2005, Investigative ophthalmology & visual science.

Mitochondrial DNA Content Increase in Response to Cigarette Smoking

J. Califano, A. Alberg, D. Sidransky, 2006, Cancer Epidemiology Biomarkers & Prevention.

Tamoxifen co-administration during controlled ovarian hyperstimulation for in vitro fertilization in breast cancer patients increases the safety of fertility-preservation treatment strategies.

S. Paluch-Shimon, B. Kaufman, Y. Cohen, 2014, Fertility and sterility.

Mutational activation of BRAF is not a major event in sporadic childhood papillary thyroid carcinoma

D. Sidransky, M. Zahurak, W. Westra, 2005, Modern Pathology.

Fragile X Premutation Carrier Epidemiology and Symptomatology in Israel—Results from a Tertiary Child Developmental Center

Y. Cohen, Shahar Shefer, S. Elizur, 2016, The Cerebellum.

Absence of AGG Interruptions Is a Risk Factor for Full Mutation Expansion Among Israeli FMR1 Premutation Carriers

E. Pras, S. Nolin, A. Hadd, 2018, Front. Genet..

Mutation analysis of the ferritin L-chain gene in age-related cataract

N. Amariglio, G. Rechavi, Y. Cohen, 2010, Molecular vision.